Tokyo Tape
Sign in
← I'rom Group

Quarterly report · Q1

2372.TEDINET S100OU1N
Period2022-04-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥4.8bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥15.7bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥3.4bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥1.4bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥354m2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥1.4bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥2.6bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥439m2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥1.5bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥440m2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.0bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥258m2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥255m2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥28.2bnat 2022-06-30Cons.Assets
Total assets¥26.6bnat 2022-03-31Cons.Assets
Total assets¥21.8bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥17.2bnat 2022-06-30Cons.Liabilities
Total liabilities¥16.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥11.0bnat 2022-06-30Cons.Net assets
Net assets / equity¥10.2bnat 2022-03-31Cons.Net assets
Net assets / equity¥8.6bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥5.9bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥6.4bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥88.372022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥162.52021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.482021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥88.222022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥162.172021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥21.422021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio38.9%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio38.1%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.3%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥19m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30−¥45m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥364m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2022-04-01 → 2022-06-30¥385m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2022-04-01 → 2022-06-30¥374m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥10m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2022-04-01 → 2022-06-30¥42m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥75m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2022-04-01 → 2022-06-30¥61m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2022-04-01 → 2022-06-30¥468m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2022-04-01 → 2022-06-30¥241m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥226m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2022-04-01 → 2022-06-30¥36m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥24m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
—segment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥337m
—segment totalsegment profit2022-04-01 → 2022-06-30¥1.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥357m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥1.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥2m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30−¥60m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥217m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥217m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥303m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2021-04-01 → 2021-06-30¥166m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2021-04-01 → 2021-06-30¥164m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥1m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2021-04-01 → 2021-06-30−¥162m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2021-04-01 → 2021-06-30¥1.1bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2021-04-01 → 2021-06-30¥1.1bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥16m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2021-04-01 → 2021-06-30¥71m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2021-04-01 → 2021-06-30¥390m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2021-04-01 → 2021-06-30¥228m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥161m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2021-04-01 → 2021-06-30¥21m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥35m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2021-04-01 → 2021-06-30¥787m
—segment totalrevenue2021-04-01 → 2021-06-30¥3.6bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥3.4bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥215m
—segment totalsegment profit2021-04-01 → 2021-06-30¥717m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥3.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥3.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥217m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥657m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 404
ItemContextValueUnit
Other noiPrior1YTDDuration124000000JPY
Other noiCurrentYTDDuration15000000JPY
Non operating incomePrior1YTDDuration136000000JPY
Non operating incomeCurrentYTDDuration220000000JPY
Interest expenses noePrior1YTDDuration23000000JPY
Interest expenses noeCurrentYTDDuration31000000JPY
Loss on investment of securities noePrior1YTDDuration－JPY
Loss on investment of securities noeCurrentYTDDuration134000000JPY
Commission fee noePrior1YTDDuration25000000JPY
Commission fee noeCurrentYTDDuration66000000JPY
Other noePrior1YTDDuration2000000JPY
Other noeCurrentYTDDuration4000000JPY
Non operating expensesPrior1YTDDuration51000000JPY
Non operating expensesCurrentYTDDuration237000000JPY
Ordinary incomePrior1YTDDuration439000000JPY
Ordinary incomeCurrentYTDDuration1432000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration0JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration59000000JPY
Extraordinary incomePrior1YTDDuration0JPY
Extraordinary incomeCurrentYTDDuration59000000JPY
Income before income taxesPrior1YTDDuration440000000JPY
Income before income taxesCurrentYTDDuration1492000000JPY
Income taxes currentPrior1YTDDuration182000000JPY
Income taxes currentCurrentYTDDuration379000000JPY
Income taxes deferredPrior1YTDDuration1000000JPY
Income taxes deferredCurrentYTDDuration38000000JPY
Income taxesPrior1YTDDuration184000000JPY
Income taxesCurrentYTDDuration418000000JPY
Profit lossPrior1YTDDuration255000000JPY
Profit lossCurrentYTDDuration1074000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration258000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration1067000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-3000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration6000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-125000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration48000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration-19000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration18000000JPY
Other comprehensive incomePrior1YTDDuration-144000000JPY
Other comprehensive incomeCurrentYTDDuration66000000JPY
Comprehensive incomePrior1YTDDuration110000000JPY
Comprehensive incomeCurrentYTDDuration1140000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration114000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration1133000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-3000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration6000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E05352-000SMOReportableSegmentsMember1870000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E05352-000CROReportableSegmentMember1119000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E05352-000AdvancedMedicinalTreatmentReportableSegmentMember164000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E05352-000MedicalSupportReportableSegmentsMember228000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass